Trump Administration Advances Multiple Policy Actions Across Health, Education, Climate and Coastal Regulation

Between late July and early September 2026, the Trump administration announced several distinct policy actions. These included a proposed regulation to strip tax-exempt status from private schools offering race-targeted programs, an agreement with nine pharmaceutical companies aimed at lowering treatment costs for conditions including Parkinson's disease, macular degeneration, glaucoma and liver disease, the wind-down of a Medicare drug subsidy program, the termination of federal funding for the Arctic Report Card climate research effort, and a federal review of California's Coastal Management Program tied to offshore oil drilling and pipeline policy. The Medicare subsidy change was reported by both The New York Times and the Associated Press, which said the move could result in higher prescription drug premiums for millions of older Americans starting next year, though exact cost figures per beneficiary were not detailed in available reporting. CBS News reported the pharmaceutical pricing agreements were announced by the White House and framed as reducing treatment costs for several serious illnesses, though specific pricing figures or implementation timelines were not specified. PBS NewsHour reported the Arctic Report Card defunding as part of a broader pattern of the administration curtailing federally supported climate change research, with glaciologist Twila Moon, the report's editor, discussing the decision's implications. California's governor's office confirmed the state formally submitted comments opposing the administration's coastal program review following a federal request for public input. The tax-exempt school proposal, reported by Fox News, remains in a proposed regulatory stage with no confirmed final rule or implementation date noted in available sources. The Medicare subsidy program's end and its downstream effects on consumer costs were still being assessed by outlets at time of reporting, with the full scope of affected beneficiaries unclear. The California coastal review remains an open federal proceeding, with the state's opposition submitted as public comment rather than a final resolution. No single source in this set independently corroborated details across all five separate actions, and each policy matter should be treated as a distinct, unresolved development pending further federal action or clarification.